BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 9, 2008
View Archived Issues
Novel class of bacterial topoisomerase II inhibitors reported by Pharmacia
Read More
Indomethacin silicon-amide derivatives may have improved physiological activity
Read More
First-in-class inhibitors of EWS-FLI1 protein potentially effective against Ewing's sarcoma
Read More
Johnson & Johnson's R-231857 shows benefit in a model of cognitive impairment in healthy men
Read More
Lilly to fund rodent studies of Corcept's selective GRII receptor antagonist CORT-108297
Read More
UNC to conduct phase IIa clinical trial of Discovery's KL-4 surfactant in CF
Read More
Recent GlaxoSmithKline patent claims new compounds for cardiovascular conditions
Read More
Mutual submits NDA to FDA for antihyperlipidemic drug MPC-028
Read More
U.S. Army to provide Neuren with additional funding for phase II trial of NNZ-2566
Read More
Protox completes enrollment in phase II trial of PRX-302 in BPH
Read More
Novel antipsychotic profile described for Pierre Fabre's F-16615
Read More
Novel PAR1 antagonists discovered at Pierre Fabre
Read More
Ardea Biosciences describes discovery of MEK inhibitor RDEA-119
Read More
Structure-activity relationship analysis of novel IKKbeta inhibitors leads to AS-1950930
Read More
Polidocanol sclerotherapy product is effective in varicose vein treatment
Read More
Sumatriptan oral spray effective in migraine headache relief at lower dose than tablets
Read More
Palifosfamide studied in new phase II trial for soft tissue sarcoma
Read More
iCo-009 advances towards clinic
Read More
MDRNA awarded further funding for research in RNA inhibition of influenza
Read More
GMI-1070 enters clinic for vaso-occlusive crisis of sickle cell disease
Read More
SARcode begins phase I trial for LFA-1 product candidate
Read More
Histalean begins phase II female obesity study
Read More
Progenics starts phase I prostate cancer study of PSMA antibody-drug conjugate
Read More
New treatment options for urinary incontinence described in recent Toray patent
Read More
BioSante clinical results for Pill-Plus triple hormone therapy
Read More
Pharmasset reports preliminary results of R-7128 proof-of-concept study in HCV
Read More